Who is iCAD?

iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.

Recent News

December 7, 2018
iCAD Announces FDA Clearance of ProFound AI™ for Digital Breast Tomosynthesis

November 26, 2018
iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018

November 13, 2018
iCAD Reports Third Quarter 2018 Financial Results

November 9, 2018
iCAD Announces Retirement of CEO, Ken Ferry

November 6, 2018
iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th

CONNECT

© 2018, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.